Company Profile

Novan Inc (AKA: Novan Therapeutics)
Profile last edited on: 1/17/2024      CAGE: 4C5W6      UEI: JVY7LPMCSFM8

Business Identifier: Nitric oxide-based drug delivery
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4105 Hopson Road
Morrisville, NC 27560
   (919) 485-8080
Location: Single
Congr. District: 04
County: Wake

Public Profile

Durham-based Novan Inc. sells all assets, files for bankruptcy. Novan is a publicly traded, clinical-stage drug development company (NASDA:NOVN) developing deliverable products that tap into the anti-bacterial properties of nitric oxide by encapsulating the compound in nano-particles that deliver therapeutic agents to desired body location. With management's goal defined as being a leader in nitric oxide-based science, technology, and clinical translation in support of delivering safe and efficacious therapies using the firm's proprietary nitric oxide-based technology platform, NITRICIL™ to generate macromolecular New Chemical Entities (NCEs) to treat multiple indications. With a particular focus on treatment of dermatological and oncovirus-mediated diseases, the Company’s core technologies solve the previous delivery issues with nitric oxide by storing the gaseous species as an engineered molecule that allows for the "timed release" of nitric oxide in short- or long-term healthcare applications. By storing nitric oxide as part of an engineered molecule, the characteristics of the framework can be controlled to tune the level of nitric oxide storage, the rate of nitric oxide release, and the molecule size to target nitric oxide delivery. The result is stabilized, drug-able nitric oxide.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Donald Hamilton -- CEO

  Nathan A Stasko -- Co-Founder, President and Chief Executive Officer

  Susanne Bauman

  Carri Geer

  Cari Green -- Associate Director, Contracts And Grants

  Stan Hollenbach -- VP of Research and Nonclinical Development

  Tim O'sullivan -- VP of Intellectual Capital

  Richard Peterson -- Chief Financial Officer

  Benjamin Joseph Privett

  M Joyce Rico -- Chief Medical Officer

  Welsey Storm